Skip to main navigation Skip to search Skip to main content

Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy

  • C.J. Bailey
  • , J.L. Gross
  • , M. Yadav
  • , N. Iqbal
  • , T.A. Mansfield
  • , J.F. List
  • Bristol-Myers Squibb, Bombay
  • Universidade Federal do Rio Grande do Sul
  • Bristol-Myers Squibb, Princeton

Research output: Contribution to journal › Conference abstract › peer-review

Fingerprint

Dive into the research topics of 'Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science